BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Cyclone causes blackout, flight chaos in Brazil's Sao Paulo - 2The face is familiar, the name might not be. The king of "Hey, it's that guy!' roles is ready to show you his next act.
- 3San Francisco sues 10 companies that make ultraprocessed food
- 4Audits of Espresso Types: Which Mix Is for You?
- 5The Best Internet based Courses for Expertise Improvement
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- World leaders, rights groups react to COP30 climate deal
- Step by step instructions to Pick the Ideal Authorize Internet Advertising Degree Program
- Woman gives birth on roadside after hospital allegedly sent her home: Family
- Mali and Canadian miner Barrick agree to resolve tax dispute, ending 2-year standoff
- Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
- 7 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- Climate engineering would alter the oceans, reshaping marine life – our new study examines each method’s risks
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
